Zobrazeno 1 - 10
of 242
pro vyhledávání: '"Quadrivalent HPV vaccine"'
Autor:
Ingrid Herta Rotstein Grein, Natalia Balera Ferreira Pinto, Noortje Groot, Camila Bertini Martins, Aline Lobo, Nadia Emi Aikawa, Cassia Barbosa, Maria Teresa Terreri, Aline Coelho Moreira da Fraga, Sheila Knupp Feitosa de Oliveira, Flavio Sztajnbok, Luciana B. Paim Marques, Aline Garcia Islabão, Simone Appenzeller, Blanca Bica, Juliana de Oliveira Sato, Claudia Saad Magalhães, Virgínia Ferriani, Hella Pasmans, Rutger Schepp, Fiona van der Klis, Sytze de Roock, Nico Wulffraat, Gecilmara Salviato Pileggi
Publikováno v:
Pediatric Rheumatology Online Journal, Vol 18, Iss 1, Pp 1-12 (2020)
Abstract Background Concerns about the safety and efficacy of vaccines in patients with autoimmune diseases (AID) have led to contradictions and low vaccination coverage in this population, who are at a higher risk of infections, including by human p
Externí odkaz:
https://doaj.org/article/a78f8a791b1b472fbb4ca734e17a247a
Autor:
Edison J. Mavundza, Alison B. Wiyeh, Phetole W. Mahasha, Gregory Halle-Ekane, Charles S. Wiysonge
Publikováno v:
Human Vaccines & Immunotherapeutics, Vol 16, Iss 2, Pp 426-435 (2020)
The human papillomavirus (HPV) is the most prevalent sexually transmitted infection worldwide. People living with the human immunodeficiency virus (HIV) are at high risk of HPV infection. This systematic review evaluates the immunogenicity, clinical
Externí odkaz:
https://doaj.org/article/a3d5b33d881947329a69caf72c7bff50
Autor:
Richard Gilson, Diarmuid Nugent, Kate Bennett, Caroline J Doré, Macey L Murray, Jade Meadows, Lewis J Haddow, Charles Lacey, Frank Sandmann, Mark Jit, Kate Soldan, Michelle Tetlow, Emilia Caverly, Mayura Nathan, Andrew J Copas
Publikováno v:
Health Technology Assessment, Vol 24, Iss 47 (2020)
Background: The comparative efficacy, and cost-effectiveness, of imiquimod or podophyllotoxin cream, either alone or in combination with the quadrivalent HPV vaccine (Gardasil®, Merck Sharp & Dohme Corp., Merck & Co., Inc., Whitehouse Station, NJ, U
Externí odkaz:
https://doaj.org/article/3ca84eeeca9748d3ba51cac0da838823
Autor:
Susanne K. Kjaer, Mari Nygård, Karin Sundström, Joakim Dillner, Laufey Tryggvadottir, Christian Munk, Sophie Berger, Espen Enerly, Maria Hortlund, Ágúst Ingi Ágústsson, Kaj Bjelkenkrantz, Katrin Fridrich, Ingibjorg Guðmundsdóttir, Sveinung Wergeland Sørbye, Oliver Bautista, Thomas Group, Alain Luxembourg, J. Brooke Marshall, David Radley, Yi Shen Yang, Cyrus Badshah, Alfred Saah
Publikováno v:
EClinicalMedicine, Vol 23, Iss , Pp 100401- (2020)
Background: The quadrivalent human papillomavirus (qHPV) vaccine prevented vaccine HPV type-related infection and disease in young women in the 4-year FUTURE II efficacy study (NCT00092534). We report long-term effectiveness and immunogenicity at the
Externí odkaz:
https://doaj.org/article/ef777c48074b460cade266cc0f37f1b9
Autor:
Macey L. Murray, Jade Meadows, Caroline J. Doré, Andrew J. Copas, Lewis J. Haddow, Charles Lacey, Mark Jit, Kate Soldan, Kate Bennett, Michelle Tetlow, Mayura Nathan, Richard Gilson
Publikováno v:
BMC Medical Research Methodology, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background Anogenital warts are the second most common sexually transmitted infection diagnosed in sexual health services in England. About 90% of genital warts are caused by human papillomavirus (HPV) types 6 or 11, and half of episodes dia
Externí odkaz:
https://doaj.org/article/3fccd0780033469f8ce7a206930a148a
Autor:
Francesca Carozzi, Donella Puliti, Cristina Ocello, Pasquale Silvio Anastasio, Espedito Antonio Moliterni, Emilia Perinetti, Laurence Serradell, Elena Burroni, Massimo Confortini, Paola Mantellini, Marco Zappa, Géraldine Dominiak-Felden
Publikováno v:
BMC Infectious Diseases, Vol 18, Iss 1, Pp 1-11 (2018)
Abstract Background A large free-of-charge quadrivalent HPV (qHPV) vaccination program, covering four cohorts annually (women 11, 14, 17 and 24 years), has been implemented in Basilicata since 2007. This study evaluated vaccine and non-vaccine HPV pr
Externí odkaz:
https://doaj.org/article/9155850d245b4278aaecbe5a580c8f74
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Carmen Hidalgo-Tenorio, Jessica Ramírez-Taboada, Concepción Gil-Anguita, Javier Esquivias, Mohamed Omar-Mohamed-Balgahata, Antonio SamPedro, Miguel Lopez-Ruz, Juan Pasquau
Publikováno v:
AIDS Research and Therapy, Vol 14, Iss 1, Pp 1-12 (2017)
Abstract Background Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine were evaluated in HIV-positive Spanish MSM. The prevalence of High Squamous Intraepithelial Lesions (HSIL) and genotypes of high-risk human papillom
Externí odkaz:
https://doaj.org/article/56d63573726a49a28e7ec2c4efb65ce3
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.